New oral antineoplastic drugs resource


happy pharmacist

A new online education course for community pharmacists will help them dispense oral antineoplastic drugs and supportive therapies to deliver maximum benefit to patients, says the Pharmacy Guild.

The Guild of Australia has announced that the new course, developed by the Cancer Institute NSW eviQ Education program, has been added to the myCPD site.

The aim of the course is to educate community pharmacists about the supply, safe handling, adverse effects and supportive therapies and potential issues surrounding oral antineoplastic treatments to ensure optimal cancer patient care.

“Increased knowledge of oral antineoplastic drugs, doses, frequencies, indications and supportive therapies will assist community pharmacies to avoid preventable adverse effects and increase the safe and effective use of these medicines,” says Professor David Currow, Chief Cancer Officer and CEO of the Cancer Institute NSW.

“It is also vital that pharmacists have the information they need to counsel patients and their carers on managing side effects, treatment adherence and supportive therapies.

“The online course developed by the Cancer Institute NSW ensures that pharmacists have this information, so they can best support members of their community affected by cancer.”

The content of this online course was developed in consultation with key representatives from community pharmacy, oncology pharmacists and relevant professional bodies.

The online course encompasses key learning activities including general principles in cancer treatment, handling oral antineoplastic drugs and related wastes, prescriptions and protocols, adverse effects and supportive therapies, drug interactions and patient education.

Anthony Tassone, the President of the Victorian Branch of the Pharmacy Guild of Australia, and a community pharmacist, says he believes that this online course will provide important advice to community pharmacists regarding the common side effects, interactions and toxicities associated with these agents.

“This is an emerging and growing area of practice for community pharmacy and through increased knowledge and awareness of oral antineoplastic treatments the community pharmacist will be better equipped to assist cancer patients in the management of their adverse effects and treatment related queries.”

The completion of this online course will attract 10 CPD credit points and is available on the Guild Academy’s myCPD site.

Previous Antidepressants ineffective for under 18s
Next SHPA support for Advanced Practice credentialing to carry on

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.